바이오프로세스 분석기 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 종류별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Bioprocess Analyzers Market Summary

The global bioprocess analyzers market size was estimated at USD 2.17 billion in 2024 and is projected to reach USD 4.57 billion by 2033, growing at a CAGR of 8.81% from 2025 to 2033. The bioprocess analyzers market is witnessing steady growth, primarily driven by the rising demand for biologics, biosimilars, and cell and gene therapies.

As biopharmaceutical production becomes more complex, companies are increasingly focusing on process optimization and real-time quality monitoring. Bioprocess analyzers enable continuous measurement of key parameters such as glucose, lactate, amino acids, and dissolved gases, ensuring higher yield, consistency, and compliance with regulatory standards.

Global Bioprocessing Analyzers Market Report Segmentation

This report forecasts revenue growth and provides an analysis on the latest trends in each of the sub-segments from 2021 to 2033. For the purpose of this report, Grand View Research has segmented the global bioprocess analyzers market on the basis of product, type, application, end use, and region.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Instruments
• Consumables
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Substrate analysis
• Metabolite analysis
• Concentration detection
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Antibiotics
• Recombinant proteins
• Biosimilars
• Other applications
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Biopharmaceutical companies
• CROs & CMOs
• Research & academic institutes
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
  • 1.1.1. Product Segment
  • 1.1.2. Type Segment
  • 1.1.3. Application Segment
  • 1.1.4. End Use Segment
• 1.2. Regional Scope
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Primary Research
• 1.6. Information or Data Analysis:
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Validation
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. List of Abbreviations
• 1.11. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Shift toward automation and digitalization in bioprocessing
    • 3.2.1.2. Growing investments in biopharmaceutical R&D and expanding biomanufacturing capacities globally
    • 3.2.1.3. Rising adoption of process analytical technology
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High capital and operating costs
    • 3.2.2.2. Stringent validation and compliance requirements
• 3.3. Industry Analysis Tools
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. PESTEL Analysis

Chapter 4. Product Business Analysis

• 4.1. Product Segment Dashboard
• 4.2. Bioprocess Analyzers Market Product Movement Analysis
• 4.3. Bioprocess Analyzers Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
• 4.4. Instruments
  • 4.4.1. Instruments market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Consumables
  • 4.5.1. Consumables market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Type Business Analysis

• 5.1. Type Segment Dashboard
• 5.2. Bioprocess Analyzers Market Type Movement Analysis
• 5.3. Bioprocess Analyzers Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 5.4. Substrate analysis
  • 5.4.1. Substrate analysis market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Metabolite analysis
  • 5.5.1. Metabolite analysis market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Concentration detection
  • 5.6.1. Concentration detection market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Application Group Business Analysis

• 6.1. Application Segment Dashboard
• 6.2. Bioprocess Analyzers Market Application Movement Analysis
• 6.3. Bioprocess Analyzers Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Antibiotics
  • 6.4.1. Antibiotics market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Recombinant proteins
  • 6.5.1. Recombinant proteins market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Biosimilars
  • 6.6.1. Biosimilars market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Others
  • 6.7.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. End Use Business Analysis

• 7.1. End Use Segment Dashboard
• 7.2. Bioprocess Analyzers Market End Use Movement Analysis
• 7.3. Bioprocess Analyzers Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 7.4. Biopharmaceutical companies
  • 7.4.1. Biopharmaceutical companies market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. CROs & CMOs
  • 7.5.1. CROs & CMOs market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.6. Research & academic institutes
  • 7.6.1. Research & academic institutes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.7. Other
  • 7.7.1. Other market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Regional Business Analysis by Product, Type, Application, End Use

• 8.1. Regional Dashboard
• 8.2. Market Size & Forecast and Trend Analysis, 2024 & 2033
• 8.3. North America
  • 8.3.1. North America Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.3.2. U.S.
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Competitive Scenario
    • 8.3.2.3. Regulatory Framework
    • 8.3.2.4. U.S. Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.3.3. Canada
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Competitive Scenario
    • 8.3.3.3. Regulatory Framework
    • 8.3.3.4. Canada Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.3.4. Mexico
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Competitive Scenario
    • 8.3.4.3. Regulatory Framework
    • 8.3.4.4. Mexico Bioprocess analyzers market, 2021 - 2033 (USD Million)
• 8.4. Europe
  • 8.4.1. Europe Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.4.2. UK
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Competitive Scenario
    • 8.4.2.3. Regulatory Framework
    • 8.4.2.4. UK Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.4.3. Germany
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Competitive Scenario
    • 8.4.3.3. Regulatory Framework
    • 8.4.3.4. Germany Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.4.4. France
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Competitive Scenario
    • 8.4.4.3. Regulatory Framework
    • 8.4.4.4. France Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.4.5. Italy
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Competitive Scenario
    • 8.4.5.3. Regulatory Framework
    • 8.4.5.4. Italy Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.4.6. Spain
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Competitive Scenario
    • 8.4.6.3. Regulatory Framework
    • 8.4.6.4. Spain Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.4.7. Denmark
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Competitive Scenario
    • 8.4.7.3. Denmark Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.4.8. Sweden
    • 8.4.8.1. Key Country Dynamics
    • 8.4.8.2. Competitive Scenario
    • 8.4.8.3. Regulatory Framework
    • 8.4.8.4. Sweden Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.4.9. Norway
    • 8.4.9.1. Key Country Dynamics
    • 8.4.9.2. Competitive Scenario
    • 8.4.9.3. Regulatory Framework
    • 8.4.9.4. Norway Bioprocess analyzers market, 2021 - 2033 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Asia Pacific Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.5.2. Japan
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Competitive Scenario
    • 8.5.2.3. Japan Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.5.3. China
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Competitive Scenario
    • 8.5.3.3. China Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.5.4. India
    • 8.5.4.1. Key Country Dynamics
    • 8.5.4.2. Competitive Scenario
    • 8.5.4.3. Regulatory Framework
    • 8.5.4.4. India Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.5.5. Australia
    • 8.5.5.1. Key Country Dynamics
    • 8.5.5.2. Competitive Scenario
    • 8.5.5.3. Regulatory Framework
    • 8.5.5.4. Australia Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key Country Dynamics
    • 8.5.6.2. Competitive Scenario
    • 8.5.6.3. Regulatory Framework
    • 8.5.6.4. Thailand Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.5.7. South Korea
    • 8.5.7.1. Key Country Dynamics
    • 8.5.7.2. Competitive Scenario
    • 8.5.7.3. Regulatory Framework
    • 8.5.7.4. South Korea Bioprocess analyzers market, 2021 - 2033 (USD Million)
• 8.6. Latin America
  • 8.6.1. Latin America Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.6.2. Brazil
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Competitive Scenario
    • 8.6.2.3. Regulatory Framework
    • 8.6.2.4. Brazil Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.6.3. Argentina
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Competitive Scenario
    • 8.6.3.3. Regulatory Framework
    • 8.6.3.4. Argentina Bioprocess analyzers market, 2021 - 2033 (USD Million)
• 8.7. MEA
  • 8.7.1. MEA Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.7.2. South Africa
    • 8.7.2.1. Key Country Dynamics
    • 8.7.2.2. Competitive Scenario
    • 8.7.2.3. Regulatory Framework
    • 8.7.2.4. South Africa Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.7.3. Saudi Arabia
    • 8.7.3.1. Key Country Dynamics
    • 8.7.3.2. Competitive Scenario
    • 8.7.3.3. Regulatory Framework
    • 8.7.3.4. Saudi Arabia Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.7.4. UAE
    • 8.7.4.1. Key Country Dynamics
    • 8.7.4.2. Competitive Scenario
    • 8.7.4.3. Regulatory Framework
    • 8.7.4.4. UAE Bioprocess analyzers market, 2021 - 2033 (USD Million)
  • 8.7.5. Kuwait
    • 8.7.5.1. Key Country Dynamics
    • 8.7.5.2. Competitive Scenario
    • 8.7.5.3. Regulatory Framework
    • 8.7.5.4. Kuwait Bioprocess analyzers market, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Company Categorization
• 9.2. Strategy Mapping
• 9.3. Company Market Position Analysis, 2024
• 9.4. Company Profiles/Listing
  • 9.4.1. Agilent Technologies
    • 9.4.1.1. Overview
    • 9.4.1.2. Financial Performance
    • 9.4.1.3. Product Benchmarking
    • 9.4.1.4. Strategic Initiatives
  • 9.4.2. Danaher Corporation
    • 9.4.2.1. Overview
    • 9.4.2.2. Financial Performance
    • 9.4.2.3. Product Benchmarking
    • 9.4.2.4. Strategic Initiatives
  • 9.4.3. Eppendorf AG
    • 9.4.3.1. Overview
    • 9.4.3.2. Financial Performance
    • 9.4.3.3. Product Benchmarking
    • 9.4.3.4. Strategic Initiatives
  • 9.4.4. F. Hoffmann-La Roche Ltd.
    • 9.4.4.1. Overview
    • 9.4.4.2. Financial Performance
    • 9.4.4.3. Product Benchmarking
    • 9.4.4.4. Strategic Initiatives
  • 9.4.5. Nova Biomedical
    • 9.4.5.1. Overview
    • 9.4.5.2. Financial Performance
    • 9.4.5.3. Product Benchmarking
    • 9.4.5.4. Strategic Initiatives
  • 9.4.6. Randox Laboratories Ltd.
    • 9.4.6.1. Overview
    • 9.4.6.2. Financial Performance
    • 9.4.6.3. Product Benchmarking
    • 9.4.6.4. Strategic Initiatives
  • 9.4.7. Sartorius AG
    • 9.4.7.1. Overview
    • 9.4.7.2. Financial Performance
    • 9.4.7.3. Product Benchmarking
    • 9.4.7.4. Strategic Initiatives
  • 9.4.8. Solida Biotech GmBH
    • 9.4.8.1. Overview
    • 9.4.8.2. Financial Performance
    • 9.4.8.3. Product Benchmarking
    • 9.4.8.4. Strategic Initiatives
  • 9.4.9. SYSBIOTECH GmbH
    • 9.4.9.1. Overview
    • 9.4.9.2. Financial Performance
    • 9.4.9.3. Product Benchmarking
    • 9.4.9.4. Strategic Initiatives
  • 9.4.10. Thermo Fisher Scientific Inc.
    • 9.4.10.1. Overview
    • 9.4.10.2. Financial Performance
    • 9.4.10.3. Product Benchmarking
    • 9.4.10.4. Strategic Initiatives